[Recent advances in theragnostics and new perspectives in molecular radiotherapy].
Theragnostics represents an attractive approach in nuclear medicine as it combines diagnostics and therapy using the same molecular target by switching gamma- or positron-emitting radionuclides with alpha, beta- or Auger electron emitting radionuclides. Radioligand therapy targeting PSMA and somatostatin receptors alre...